Gary Richmond

机构：Broward Health Medical Center, Broward Health

发表论文 60 篇 · 总被引 5191 次 · h-index 27

代表论文

• Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression (2020 · New England Journal of Medicine · 被引 581)
• Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial (2017 · The Lancet · 被引 505)
• Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study (2020 · The Lancet · 被引 375)
• Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection (2022 · New England Journal of Medicine · 被引 312)
• Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1 (2018 · New England Journal of Medicine · 被引 226)
• Experiences with long acting injectable ART: A qualitative study among PLHIV participating in a Phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and Spain (2018 · PLoS ONE · 被引 179)